NASDAQ:LMNX • US88636W7671
The current stock price of LMNX is 20.9464 USD. In the past month the price decreased by -42.9%.
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 20.34 | 189.666B | ||
| DHR | DANAHER CORP | 25.03 | 150.273B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 133.24 | 44.271B | ||
| A | AGILENT TECHNOLOGIES INC | 20.78 | 35.584B | ||
| IQV | IQVIA HOLDINGS INC | 12.76 | 28.313B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 29.44 | 27.668B | ||
| WAT | WATERS CORP | 22.35 | 19.25B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 31.91 | 18.02B | ||
| ILMN | ILLUMINA INC | 22.56 | 17.849B | ||
| MEDP | MEDPACE HOLDINGS INC | 25.46 | 12.058B |
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find more ETFs on the USA exchanges | Find stocks with similar TA and Setup ratings on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges
Luminex Corp. develops, manufactures and markets proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries. The company is headquartered in Austin, Texas and currently employs 1,325 full-time employees. The company went IPO on 2000-03-30. The firm's products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease segments. The firm has a range of instruments using its xMAP technology, which includes its LUMINEX 100/200 systems offer 100-plex testing; the Company's FLEXMAP 3D system is its high-throughput, 500-plex testing system, and its MAGPIX system provides 50-plex testing using imaging rather than flow cytometry. By using its xMAP technology, the end users are able to generate multiple simultaneous results per sample. The firm primarily serves the diagnostics, pharmaceutical and life sciences industries by marketing products, including its testing equipment and assays, to a range of testing laboratories.
The current stock price of LMNX is 20.9464 USD. The price increased by 4.69% in the last trading session.
LMNX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on LMNX.